Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
568,093,200
-
Share change
-
-25,752,117
-
Total reported value
-
$26,108,610,817
-
Put/Call ratio
-
99%
-
Price per share
-
$46.01
-
Number of holders
-
787
-
Value change
-
-$1,245,501,967
-
Number of buys
-
328
-
Number of sells
-
391
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2016
As of 30 Sep 2016,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
787 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
568,093,200 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, Capital Research Global Investors, Viking Global Investors LP, LAZARD ASSET MANAGEMENT LLC, WADDELL & REED FINANCIAL INC, Bank of New York Mellon Corp, PAULSON & CO. INC., and Invesco Ltd..
This page lists
787
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.